Citation Impact
Citing Papers
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres
2002 StandoutNobel
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma
2006
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
1999 Standout
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
1991 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Electron microscopic study of (A)BC excinuclease
1992 StandoutNobel
Secreted proteins and genes in fetal and neonatal pig adipose tissue and stromal-vascular cells1
2006
Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice
2002 StandoutNobel
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Cushing's syndrome
2015 Standout
Paclitaxel (Taxol)
1995 Standout
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis
1996 Standout
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
1988
Machine learning applications in cancer prognosis and prediction
2014 Standout
Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments
1991 StandoutNobel
Chemotherapy in malignant mesothelioma: a review
1991
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamide
1989
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
1995
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.
1994
Chemotherapy in malignant pleural mesothelioma. A review.
1996
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Management of malignant pleural effusions
2001 Standout
A Review of Chemotherapy Trials for Malignant Mesothelioma
1998
High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
1990
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
1992
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered
1992
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Cancer of the Ovary
2004 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Prognostic factors in advanced ovarian carcinoma.
1986
Clinical pharmacology of intraperitoneal cisplatin
1985
Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties.
1980
Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
1986
Adipose-Derived Stem Cells for Regenerative Medicine
2007 Standout
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Intermediate filament proteins in nonfilamentous structures: Transient disintegration and inclusion of subunit proteins in granular aggregates
1982
Ovarian cancer: new clinical approaches
1991
Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells
1984
Ectopic adrenocorticotrophic (ACTH) syndrome and small cell carcinoma of the lung—assessment of clinical implications in patients on combination chemotherapy
1981
Procedure for freeze-drying molecules adsorbed to mica flakes
1983
Advanced Ovarian Cancer: Long-Term Results of Treatment with Intensive Cisplatin-Based Chemotherapy of Brief Duration
1988
Direct observation of kinetic traps associated with structural transformations leading to multiple pathways of S-layer assembly
2012 StandoutNobel
The actin-binding protein Hip1R associates with clathrin during early stages of endocytosis and promotes clathrin assembly in vitro
2001 StandoutNobel
Surface structure of the COPII-coated vesicle
2001 StandoutNobel
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung
1987
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.
1985
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
1988 Standout
Pleural mesothelioma: combined modality treatments
2002
Treatment selection for cancer patients: Application of statistical decision theory to the treatment of advanced ovarian cancer
1985
Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.
1984
The fibrillar substructure of keratin filaments unraveled.
1983
Ovarian cancer in the elderly: An analysis of Surveillance, Epidemiology, and End Results Program data
1986
A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study
1986
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of Richardson Rl being referenced
Tumor products and potential markers in small cell lung cancer.
1978
Disassembly of synthetic 10-nm desmin filaments from smooth muscle into protofilaments.
1981
Small cell lung cancer: progress and perspectives.
1978
Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.
1981
Secretion of insulin-like growth factor (IGF)-I and -II and IGF binding proteins (IGFBPs) in fetal stromal-vascular (S-V) cell cultures obtained before and after the onset of adipogenesis in vivo.
2002
Phase II trial of diaziquone in malignant mesothelioma.
1986
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
1982